Herb Greenberg is the editor of Herb Greenberg's Reality Check, a subscription newsletter designed to help investors better manage risk. He writes a daily blog for TheStreet's main free website and contributes to its Real Money's "Columnist Conversation" column as well as being a regular contributor for CNBC.
Greenberg has been a financial journalist for more than 30 years, working most recently as a senior stocks commentator on CNBC's Business Day programming and on CNBC.com. He was also co-president of Greenberg Meritz Research & Analytics. He is a former weekend investor columnist for The Wall Street Journal and a former senior columnist for MartketWatch.
Prior to joining MarketWatch, Greenberg was senior columnist for TheStreet.com. He previously spent 10 years as the "Business Insider" columnist for the San Francisco Chronicle and nearly seven years as Fortune magazine's monthly "Against the Grain" columnist.
He also was the New York financial correspondent for the Chicago Tribune and a financial reporter in its Chicago newsroom. Greenberg has held various positions at other media outlets including Crain's Chicago Business and the St. Paul Pioneer Press.
Greenberg holds a bachelor's degree in journalism from the University of Miami.
Follow Herb Greenberg on Twitter @herbgreenberg.
Since 2008, the FDA has issued 5 pages of recalls against Intuitive Surgical. CNBC's Herb Greenberg discusses potential risks to the company's reputation, and how investors are reacting.
Shares of Take-Two slid after the company said it would buy back all of activist investor Carl Icahn's shares. CNBC contributor Herb Greenberg discusses buyback rules for investors. Andrew Stoltmann, Stoltmann Law Offices, and CNBC's Kayla Tausche weigh in.